Alexander Alanine

3.1k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Alexander Alanine is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alexander Alanine has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alexander Alanine's work include Neuroscience and Neuropharmacology Research (8 papers), Synthesis of heterocyclic compounds (6 papers) and Chemical Synthesis and Analysis (5 papers). Alexander Alanine is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Synthesis of heterocyclic compounds (6 papers) and Chemical Synthesis and Analysis (5 papers). Alexander Alanine collaborates with scholars based in Switzerland, Canada and Germany. Alexander Alanine's co-authors include Konrad Bleicher, Hans‐Joachim Böhm, Klaus Müller, Gerhard Trube, Gisbert Schneider, Pascal Pflimlin, Olivier Roche, Rainer E. Martin, Vincent Mutel and Anne Bourson and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Reviews Drug Discovery and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Alexander Alanine

26 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hit and lead generation: beyond high-throughput screening

2003 729 citations Konrad Bleicher, Hans‐Joachim Böhm et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Alexander Alanine

Since Specialization

Citations

This map shows the geographic impact of Alexander Alanine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Alanine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Alanine more than expected).

Fields of papers citing papers by Alexander Alanine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Alanine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Alanine. The network helps show where Alexander Alanine may publish in the future.

Co-authorship network of co-authors of Alexander Alanine

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Alanine. A scholar is included among the top collaborators of Alexander Alanine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Alanine. Alexander Alanine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nahtlose Integration von Dosis‐Wirkungs‐basiertem Screening und Flusschemie: effiziente Erzeugung von Struktur‐Aktivitäts‐Beziehungen von β‐Sekretase(BACE1)‐Hemmern 2014 ·Angewandte Chemie ·(unknown), (unknown), Rainer E. Martin, Remo Hochstrasser, (unknown), (unknown), Alexander Alanine, Horst Vogel	3
2	Seamless Integration of Dose‐Response Screening and Flow Chemistry: Efficient Generation of Structure–Activity Relationship Data of β‐Secretase (BACE1) Inhibitors 2014 ·Angewandte Chemie International Edition ·(unknown), (unknown), Rainer E. Martin, Remo Hochstrasser, (unknown), (unknown), Alexander Alanine, Horst Vogel	35
3	Towards the enantioselective synthesis of (−)-euonyminol – preparation of a fully functionalised lower-rim model 2013 ·Organic & Biomolecular Chemistry ·Matthew J. Webber, (unknown), D.M. Grainger, Matthew Weston, (unknown), Steven J. Woodhead, (unknown), S.P. Stokes, Alexander Alanine, (unknown), Christopher S. Frampton, Andrew J. P. White, Alan C. Spivey	17
4	Neighborhood‐Preserving Visualization of Adaptive Structure–Activity Landscapes: Application to Drug Discovery 2011 ·Angewandte Chemie International Edition ·Michael Reutlinger, Wolfgang Guba, Rainer E. Martin, Alexander Alanine, Torsten Hoffmann, Alexander Klenner, Jan A. Hiss, Petra Schneider, Gisbert Schneider	34
5	Neighborhood‐Preserving Visualization of Adaptive Structure–Activity Landscapes: Application to Drug Discovery 2011 ·Angewandte Chemie ·Michael Reutlinger, Wolfgang Guba, Rainer E. Martin, Alexander Alanine, Torsten Hoffmann, Alexander Klenner, Jan A. Hiss, Petra Schneider, Gisbert Schneider	9
6	Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: Optimising brain penetration 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jens‐Uwe Peters, Thomas Lübbers, Alexander Alanine, Sabine Kolczewski, Francesca Blasco, Lucinda J. Steward	20
7	Synthesis and characterization of 8-ethynyl-1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: New potent non-competitive metabotropic glutamate receptor 2/3 antagonists. Part 1 2007 ·Bioorganic & Medicinal Chemistry Letters ·Thomas J. Woltering, Geo Adam, Alexander Alanine, Jürgen Wichmann, Frédéric Knoflach, Vincent Mutel, Silvia Gatti	21
8	Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: Structure–activity relationship elucidation 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jens‐Uwe Peters, Thomas Lübbers, Alexander Alanine, Sabine Kolczewski, Francesca Blasco, Lucinda J. Steward	9
9	Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process 2003 ·Combinatorial Chemistry & High Throughput Screening ·Alexander Alanine, Matthias Nettekoven, Edward Roberts, Andrew W. Thomas	38
10	2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Bernd Büttelmann, Alexander Alanine, Anne Bourson, Ramanjit Gill, (unknown), Vincent Mutel, Emmanuel Pinard, Gerhard Trube, R. Wyler	18
11	4-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Bernd Büttelmann, Alexander Alanine, Anne Bourson, Ramanjit Gill, (unknown), Vincent Mutel, Emmanuel Pinard, Gerhard Trube, R. Wyler	11
12	1-Benzyloxy-4,5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Alexander Alanine, Anne Bourson, Bernd Büttelmann, Ramanjit Gill, (unknown), Vincent Mutel, Emmanuel Pinard, Gerhard Trube, R. Wyler	21
13	Hit and lead generation: beyond high-throughput screening breakdown → 2003 ·Nature Reviews Drug Discovery ·Konrad Bleicher, Hans‐Joachim Böhm, Klaus Müller, Alexander Alanine	729
14	Synthesis and SAR evaluation of 1,2,4-triazoles as A2A receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Alexander Alanine, Lilli Anselm, Lucinda J. Steward, (unknown), (unknown), Michael D. Groaning	25
15	Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis 2002 ·RePEc: Research Papers in Economics ·(unknown), (unknown), (unknown), (unknown), Helen J. Lachmann, (unknown), Laurence Lovat, (unknown), Alexander Alanine, Cornelia Hertel, (unknown), Roland Jakob‐Roetne, (unknown), J A Kemp, (unknown), Miho Suzuki, Glyn Taylor, Stephen A. Murray, Darren A. Thompson, A. C. Purvis, Simon Kolstoe, (unknown), Philip N. Hawkins	1
16	Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-Selective N-Methyl-d-Aspartate Antagonist 2002 ·Journal of Pharmacology and Experimental Therapeutics ·R. Gill, Alexander Alanine, Anne Bourson, Bernd Büttelmann, G. Fischer, M. Heitz, James N.C. Kew, Bernard Levet‐Trafit, H.P. Lorez, Pari Malherbe, (unknown), Vincent Mutel, Emmanuel Pinard, S. Roever, Martine Schmitt, Gerhard Trube, (unknown), R. Wyler, John A. Kemp	45
17	4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists 2002 ·Bioorganic & Medicinal Chemistry Letters ·Emmanuel Pinard, Alexander Alanine, Anne Bourson, Bernd Büttelmann, (unknown), (unknown), Gerhard Trube, R. Wyler	21
18	A Virtual Screening Method for Prediction of the hERG Potassium Channel Liability of Compound Libraries 2002 ·ChemBioChem ·Olivier Roche, Gerhard Trube, (unknown), Pascal Pflimlin, Alexander Alanine, Gisbert Schneider	134
19	Parallel synthesis of substituted imidazoles from 1,2-aminoalcohols 2002 ·Tetrahedron Letters ·Konrad Bleicher, (unknown), (unknown), Alexander Alanine, Alfredo Capretta	49
20	Discovery of (R)-1-[2-Hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: A Novel NR1/2B Subtype Selective NMDA Receptor Antagonist 2001 ·Bioorganic & Medicinal Chemistry Letters ·Emmanuel Pinard, Alexander Alanine, Anne Bourson, Bernd Büttelmann, Ramanjit Gill, (unknown), Georg Jaeschke, Vincent Mutel, Gerhard Trube, R. Wyler	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact